-
公开(公告)号：US12271294B2
公开(公告)日：2025-04-08
申请号：US18387672
申请日：2023-11-07
Applicant: IQVIA Inc.
Inventor： Pranav P. Chapagain , Massimo Franza , Ramon Eduardo Aldana Borjes
IPC: G06F11/36 , G06F11/3668
Abstract: A requirements to test (R2T) system is implemented, which provides an automated system by which a user interface (UI)-test automation script package is generated and the generated test scripts therein are executed against software. A visualized workflow is translated into some machine-consumable formatted file. The translated workflow is utilized by an artificial intelligence driven automated R2T engine to discover paths through the workflow, a series of executable steps for the paths that detail how the software will be used, and ultimately test scripts that are generated using pre-defined validation templates. An automation platform executes the test scripts through the software associated with the workflow, which automatically captures evidence of the executed test scripts to fulfill computer system validation requirements. The R2T system provides an automated solution for test script creation and system validation to expedite the validation process and thereby streamline a software's time to market.
-
公开(公告)号：US20250014748A1
公开(公告)日：2025-01-09
申请号：US18347237
申请日：2023-07-05
Applicant: IQVIA Inc.
Inventor： Tong Wu , Yong Cai , Yunlong Wang , Fan Zhang , Emily Zhao , Yilian Yuan
Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for generating data structures from graphs. The computer accesses a graph having patient nodes representing patients and patient health data nodes representing health data for patients, the nodes being connected by edges. The computer generates subgraphs by identifying patient nodes and patient health data nodes associated with a particular healthcare provider. The computer generates, by a subgraph neural network, a healthcare provider data structure for a respective subgraph. The computer generates, by a first graph neural network, patient data structures for a respective patient graph network and health data structures for a respective health data graph network. Each healthcare provider data structure, patient graph network, health data structure, has a lower dimension than the corresponding subgraph, patient graph network, and health data graph network, respectively. The computer provides at least one of the data structures to a model.
-
公开(公告)号：US20240331812A1
公开(公告)日：2024-10-03
申请号：US18740246
申请日：2024-06-11
Applicant: IQVIA INC.
Inventor： Thomas Paul Haskell , Benjamin Alexander Paul Hughes
Abstract: System and method to determine a reduced cohort criteria, the method including: defining N selection criteria to select a cohort from among a universe of patient data; querying a patient database, by use of a processor, and by use of the N selection criteria, in order to define a full patient population; selecting a subset of size M of the N selection criteria, to produce a subset criteria; selecting a permutation of the subset criteria, to produce a permuted subset criteria in a predetermined order; for each member of the permuted subset criteria: querying the patient database by use of the member of the permuted subset criteria to produce a respective interim patient population; combining all respective interim patient populations to produce a partial patient population; and calculating, by a processor, a coverage figure of merit that compares the partial patient population to the full patient population.
-
公开(公告)号：USRE50117E1
公开(公告)日：2024-09-10
申请号：US17875868
申请日：2022-07-28
Applicant: IQVIA Inc.
CPC classification number: G06F21/6227 , G06F21/6245 , G16H10/60 , H04L63/102 , H04L63/105 , G06F2221/032 , G06F2221/2141
Abstract: A method and system to provide multi-layered access control for healthcare datasets are disclosed. The method comprises defining an information policy for each of healthcare datasets, wherein the information policy comprises information access permissions. Further, an organization policy is defined for each of the healthcare datasets, wherein the organization policy comprises license permissions for organizations accessing the healthcare datasets. Thereafter, a user account master policy is defined for each of the healthcare datasets, wherein the user account master policy comprises account permissions assigned to users of the organizations. Subsequently, a master user policy is generated for each of the users based on the information policy, the organization policy, the user account master policy, or a combination thereof, wherein the master user policy comprises access control permissions to provide each of the users access to the healthcare datasets.
-
公开(公告)号：US20240266010A1
公开(公告)日：2024-08-08
申请号：US18431623
申请日：2024-02-02
Applicant: IQVIA Inc.
Inventor： Aruna Thapa Adhikari , Gregory Paul Friedman , Peter Nadudvari , Naouel Baili Benabdallah , Sakti Singh , Meredith Leigh Malloy , Devi Chandrasekaran
CPC classification number: G16H10/20 , H04L63/0815 , H04L63/105
Abstract: A method includes ingesting, by a clinical trial management platform, data from multiple clinical trial site systems associated with multiple clinical trials, responsive to authentication of user credentials of a user, providing the user with access to the clinical trial management platform, based on the user credentials, identifying a particular clinical trial associated with the user, through the clinical trial management platform, providing the user with access to multiple clinical trial software services based on the authenticated user credentials, based on the ingested data for the particular clinical trial associated with the user, presenting to the user a user-specific task list for user tasks related to the particular clinical trial; and through the clinical trial management platform, establishing a communication link between the user and another user, the communication link enabling direct, real-time messaging via the clinical trial management platform between the user and the other user.
-
Patent Agency Ranking
公开(公告)号：US12009069B2
公开(公告)日：2024-06-11
申请号：US17696059
申请日：2022-03-16
Applicant: IQVIA Inc.
Inventor： Thomas Paul Haskell , Benjamin Alexander Paul Hughes
Abstract: System and method to determine a reduced cohort criteria, the method including: defining N selection criteria to select a cohort from among a universe of patient data; querying a patient database, by use of a processor, and by use of the N selection criteria, in order to define a full patient population; selecting a subset of size M of the N selection criteria, to produce a subset criteria; selecting a permutation of the subset criteria, to produce a permuted subset criteria in a predetermined order; for each member of the permuted subset criteria: querying the patient database by use of the member of the permuted subset criteria to produce a respective interim patient population; combining all respective interim patient populations to produce a partial patient population; and calculating, by a processor, a coverage figure of merit that compares the partial patient population to the full patient population.
-
27.发明授权公开(公告)号：US12002554B2
公开(公告)日：2024-06-04
申请号：US17710090
申请日：2022-03-31
Applicant: IQVIA Inc.
Inventor： Peter Hassett
IPC: G06F40/197 , G06F40/174 , G16H10/20 , G06F3/0482
CPC classification number: G16H10/20 , G06F40/174 , G06F40/197 , G06F3/0482
Abstract: A method of managing consent using a computing device, the consent is given by a subject to one or more events in one or more studies, wherein the consent and the plurality of activities are changeable, the method including: authoring one or more first data forms describing the one or more events and one or more selections responsive to the one or more events; authoring, for each of the plurality of subjects, one or more second data forms including description of a plurality of preferences; forming, for a first of the plurality of subjects, an Informed Consent Forms document by combining the one or more first data forms of a first of the one or more studies and one or more second data forms for the first subject; and generating a manifest indicating the one or more events in the first study to which the first subject has granted consent.
-
公开(公告)号：US20240006041A1
公开(公告)日：2024-01-04
申请号：US18217537
申请日：2023-07-01
Applicant: IQVIA Inc.
Inventor： Jonathan Walter , Sumanta Sharma , Bradley Kwon , Brian Wilson Williams
Abstract: A method includes receiving data images of patient medications. The method also creates a training set using the received data images. The method also includes training a machine learning system using the training set. The machine learning system is trained to monitor shipment and inventory of the patient medications, patient enrollment in medical trials, and a distribution of the patient medications. The method also includes applying the trained machine learning system with monitoring results of the shipment and inventory of the patient medications, the patient enrollment in the medical trials, and the distribution of the patient medications.
-
公开(公告)号：US11809307B2
公开(公告)日：2023-11-07
申请号：US17412304
申请日：2021-08-26
Applicant: IQVIA Inc.
Inventor： Pranav P. Chapagain , Massimo Franza , Ramon Eduardo Aldana Borjes
IPC: G06F11/36
CPC classification number: G06F11/3688 , G06F11/3664 , G06F11/3692
Abstract: A requirements to test (R2T) system is implemented, which provides an automated system by which a user interface (UI)-test automation script package is generated and the generated test scripts therein are executed against software. A visualized workflow is translated into some machine-consumable formatted file. The translated workflow is utilized by an artificial intelligence driven automated R2T engine to discover paths through the workflow, a series of executable steps for the paths that detail how the software will be used, and ultimately test scripts that are generated using pre-defined validation templates. An automation platform executes the test scripts through the software associated with the workflow, which automatically captures evidence of the executed test scripts to fulfill computer system validation requirements. The R2T system provides an automated solution for test script creation and system validation to expedite the validation process and thereby streamline a software's time to market.
-
公开(公告)号：US20230281261A1
公开(公告)日：2023-09-07
申请号：US18189393
申请日：2023-03-24
Applicant: IQVIA Inc.
Inventor： Gary Shorter , Jaffershah Jahangeer
IPC: G06F16/955 , G16H20/00 , G06K7/14 , G06K19/06
CPC classification number: G06F16/9554 , G16H20/00 , G06K7/1417 , G06K19/06009
Abstract: Embodiments of the present disclosure provide a method for monitoring/tracking the lifecycle of a drug from build (e.g., as part of clinical trial development), to approval (e.g., regulatory), to in-market (e.g., distribution and safety information). The use of artificial intelligence (AI) and blockchain technology may enable the system to track the drug down to the prescription level and may support a digital label that can be updated as necessary based on such monitoring (e.g., that can be amended based on safety information detected while the drug is in market and warnings sent out upon amendment).
-
-
-
-
-
-
-
-
-
Search Results
123
records
(took 0.022 seconds)
